124 related articles for article (PubMed ID: 34852203)
1. Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response.
Li Z; Wang Q; Li L; Chen Y; Cui J; Liu M; Zhang N; Liu Z; Han J; Wang Z
J Med Chem; 2021 Dec; 64(24):17920-17935. PubMed ID: 34852203
[TBL] [Abstract][Full Text] [Related]
2. Development of a series of flurbiprofen and zaltoprofen platinum(IV) complexes with anti-metastasis competence targeting COX-2, PD-L1 and DNA.
Li Z; Li L; Zhao W; Sun B; Liu Z; Liu M; Han J; Wang Z; Li D; Wang Q
Dalton Trans; 2022 Aug; 51(33):12604-12619. PubMed ID: 35924963
[TBL] [Abstract][Full Text] [Related]
3. A series of ligustrazine platinum(IV) complexes with potent anti-proliferative and anti-metastatic properties that exert chemotherapeutic and immunotherapeutic effects.
Chen Y; Li L; Liu Z; Liu M; Wang Q
Dalton Trans; 2023 Sep; 52(37):13097-13109. PubMed ID: 37664893
[TBL] [Abstract][Full Text] [Related]
4. Development of Clioquinol Platinum(IV) Conjugates as Autophagy-Targeted Antimetastatic Agents.
Zhang M; Li L; Li S; Liu Z; Zhang N; Sun B; Wang Z; Jia D; Liu M; Wang Q
J Med Chem; 2023 Mar; 66(5):3393-3410. PubMed ID: 36891739
[TBL] [Abstract][Full Text] [Related]
5. Multi-specific niflumic acid platinum(IV) complexes displaying potent antitumor activities by improving immunity and suppressing angiogenesis besides causing DNA damage.
Li L; Zhang M; Jia D; Liu Z; Zhang N; Sun B; Wang Z; Liu M; Wang Q
Dalton Trans; 2022 Dec; 52(1):147-158. PubMed ID: 36472127
[TBL] [Abstract][Full Text] [Related]
6. Development of a series of 4-hydroxycoumarin platinum(IV) hybrids as antitumor agents: Synthesis, biological evaluation and action mechanism investigation.
Li G; Zhang J; Liu Z; Wang Q; Chen Y; Liu M; Li D; Han J; Wang B
J Inorg Biochem; 2019 May; 194():34-43. PubMed ID: 30826588
[TBL] [Abstract][Full Text] [Related]
7. A potent aminonaphthalimide platinum(IV) complex with effective antitumor activities in vitro and in vivo displaying dual DNA damage effects on tumor cells.
Wang Q; Chen Y; Li G; Zhao Y; Liu Z; Zhang R; Liu M; Li D; Han J
Bioorg Med Chem Lett; 2019 Oct; 29(20):126670. PubMed ID: 31500997
[TBL] [Abstract][Full Text] [Related]
8. Platinum(IV) complexes conjugated with chalcone analogs as dual targeting anticancer agents: In vitro and in vivo studies.
Huang X; Liu Z; Wang M; Yin X; Wang Y; Dai L; Wang H
Bioorg Chem; 2020 Dec; 105():104430. PubMed ID: 33171407
[TBL] [Abstract][Full Text] [Related]
9. Series of Desloratadine Platinum(IV) Hybrids Displaying Potent Antimetastatic Competence by Inhibiting Epithelial-Mesenchymal Transition and Arousing Immune Response.
Zhang M; Chen Y; Liu Z; Liu M; Wang Q
J Med Chem; 2024 Feb; 67(3):2031-2048. PubMed ID: 38232132
[TBL] [Abstract][Full Text] [Related]
10. Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug bezafibrate.
Qiao X; Gao YY; Zheng LX; Ding XJ; Xu LW; Hu JJ; Gao WZ; Xu JY
Eur J Med Chem; 2021 Nov; 223():113730. PubMed ID: 34388483
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of bi-functional 7-hydroxycoumarin platinum(IV) complexes as antitumor agents.
Wang Q; Chen Y; Li G; Liu Z; Ma J; Liu M; Li D; Han J; Wang B
Bioorg Med Chem; 2019 May; 27(10):2112-2121. PubMed ID: 30981607
[TBL] [Abstract][Full Text] [Related]
12. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties.
Choroba K; Machura B; Szlapa-Kula A; Malecki JG; Raposo L; Roma-Rodrigues C; Cordeiro S; Baptista PV; Fernandes AR
Eur J Med Chem; 2021 Jun; 218():113404. PubMed ID: 33823390
[TBL] [Abstract][Full Text] [Related]
13. Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX-2 and PD-L1.
Jin S; Muhammad N; Sun Y; Tan Y; Yuan H; Song D; Guo Z; Wang X
Angew Chem Int Ed Engl; 2020 Dec; 59(51):23313-23321. PubMed ID: 32897000
[TBL] [Abstract][Full Text] [Related]
14. Albumin-encapsulated Nanoparticles of Naproxen Platinum(IV) Complexes with Inflammation Inhibitory Competence Displaying Effective Antitumor Activities in vitro and in vivo.
Li L; Chen Y; Wang Q; Li Z; Liu Z; Hua X; Han J; Chang C; Wang Z; Li D
Int J Nanomedicine; 2021; 16():5513-5529. PubMed ID: 34429597
[TBL] [Abstract][Full Text] [Related]
15. Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM/LDHA and CCND1/BCL2/ATG3 signaling pathways.
Bai X; Ali A; Lv Z; Wang N; Zhao X; Hao H; Zhang Y; Rahman FU
Eur J Med Chem; 2021 Nov; 224():113689. PubMed ID: 34293698
[TBL] [Abstract][Full Text] [Related]
16. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
[TBL] [Abstract][Full Text] [Related]
17. Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance.
Huang X; Huang R; Gou S; Wang Z; Liao Z; Wang H
Bioorg Med Chem; 2017 Sep; 25(17):4686-4700. PubMed ID: 28728896
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J
Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828
[TBL] [Abstract][Full Text] [Related]
19. Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation.
Wang H; Yang X; Zhao C; Wang PG; Wang X
Bioorg Med Chem; 2019 Apr; 27(8):1639-1645. PubMed ID: 30852077
[TBL] [Abstract][Full Text] [Related]
20. CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic Tumors.
Cao Q; Zhou DJ; Pan ZY; Yang GG; Zhang H; Ji LN; Mao ZW
Angew Chem Int Ed Engl; 2020 Oct; 59(42):18556-18562. PubMed ID: 32557982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
